Patients with moderate to severe COVID-19 disease with following criteria : <br/ >1. Age >18 years <br/ >2. Laboratory confirmed COVID-19 patients <br/ >3. SpO2 94% <br/ >4. Patients on different modalities of oxygen therapy <br/ >5. Patients with radiologically confirmed pneumonia <br/ >6. ARDS / Acute Respiratory Failure <br/ >Presence of raised inflammatory markers e.g. CRP, ferritin, IL-6 <br/ >

Patients with moderate to severe COVID-19 disease with following criteria : <br/ >1. Age >18 years <br/ >2. Laboratory confirmed COVID-19 patients <br/ >3. SpO2 94% <br/ >4. Patients on different modalities of oxygen therapy <br/ >5. Patients with radiologically confirmed pneumonia <br/ >6. ARDS / Acute Respiratory Failure <br/ >Presence of raised inflammatory markers e.g. CRP, ferritin, IL-6 <br/ >

Patients with moderate to severe COVID-19 disease with following criteria : <br/ >1. Age >18 years <br/ >2. Laboratory confirmed COVID-19 patients <br/ >3. SpO2 94% <br/ >4. Patients on different modalities of oxygen therapy <br/ >5. Patients with radiologically confirmed pneumonia <br/ >6. ARDS / Acute Respiratory Failure <br/ >Presence of raised inflammatory markers e.g. CRP, ferritin, IL-6 <br/ >

Patients with moderate to severe COVID-19 disease with following criteria : <br/ >1. Age >18 years <br/ >2. Laboratory confirmed COVID-19 patients <br/ >3. SpO2 94% <br/ >4. Patients on different modalities of oxygen therapy <br/ >5. Patients with radiologically confirmed pneumonia <br/ >6. ARDS / Acute Respiratory Failure <br/ >Presence of raised inflammatory markers e.g. CRP, ferritin, IL-6 <br/ >